🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🏅 The BCI has awarded Professor Thomas Powles (Tom Powles) the commemorative Gordon Hamilton Fairley Medal in recognition of his outstanding work transforming outcomes in bladder cancer. (1/4)

Tom Powles Barts and The London, Queen Mary Barts Health Queen Mary University of London CRUKCOLcentre In his recent award lecture, Professor Powles reflected on the challenges and successes he faced on his journey to uncovering life-extending treatment combinations for bladder cancer. (2/4)

Tom Powles Barts and The London, Queen Mary Barts Health Queen Mary University of London CRUKCOLcentre The medal commemorates the life of Gordon Hamilton Fairley, the first Professor of Medical Oncology in England, who built a world-leading oncology unit at Barts Hospital. Tragically, Prof Fairley's life was cut short by a terrorist bomb in London in 1975 at the age of 45. (3/4)

Tom Powles Barts and The London, Queen Mary Barts Health Queen Mary University of London CRUKCOLcentre Professor Fairley was a pioneer in the fields of chemotherapy and immunotherapy, and his visionary work laid the foundations for decades of world-leading oncology research at Barts and Queen Mary's – including Professor Powles'. (4/4)

Great work from Professor Gerlinger and the GI team at Bart’s Experimental Cancer Medicine Centre ⭐️

Elegant presentation from Alex Wyatt on the evolution of ctDNA detection and characterization! Session chaired by Dana-Farber Lank Center for Genitourinary Oncology's joaquim bellmunt and Barts Experimental Cancer Medicine Centre 's Bernadett Szabados #GU25 ASCO OncoAlert OncLive.com

Terrific work by Tom Powles !! With >2 years of follow-up, 1L EV+P maintains superior OS and PFS vs chemo in la/mUC. cCR rate doubled (30.4% vs 14.5%), with longer response durability and no new safety signals. EV+P remains SOC! Barts Cancer Institute (Queen Mary) Shilpa Gupta ASCO #GU25 OncoAlert

Updated data from the transformative EV302 trial led by Tom Powles presented at ASCO GU today reinforcing the EV+P combination as a new frontline standard of care for bladder cancer patients #GU25 ASCO Uromigos Tres Uramigas

Dr Elizabeth Nally Beth Nally from Barts Experimental Cancer Medicine Centre presents at #GU25 QoL tools and toxicity definitions require re-evaluation in the IO era. She validates novel tools within PRISM, a ph2 RCT. Response to Tx appears to influence QoL more than any other parameter, incl life changing tox

Dr Francesca Jackson-Spence, PhD candidate at Barts Experimental Cancer Medicine Centre presents final survival data and a novel ctDNA analysis from the Barts Cancer Institute (Queen Mary) led phase II CALYPSO trial at ASCO #GU25 looking at targeting MET in advanced papillary renal cancer drfrankiejs

Dr Connor Wells presents interesting real world data from Barts Experimental Cancer Medicine Centre showing how clinical trials matter! > 50% of our patients join kidney and bladder cancer trials where available at our centre ASCO #GU25

Final survival data and ctDNA data from the CALYPSO trial presented by Dr Francesca Jackson-Spence at ASCO #GU25 - RR and OS are enhanced in MET-driven papillary RCC. ctDNA at baseline is prognostic. CtDNA may be a useful tool in papRCC Barts Cancer Institute (Queen Mary) Tom Powles UroToday.com drfrankiejs

Watch my UroToday.com interview summarising the papillary CALYPSO trial final survival data and ctDNA analysis. Originally presented at ASCO #GU25 urotoday.com/video-lectures…

#CALYPSO trial: Savolitinib and durvalumab in advanced papillary #RenalCancer. Francesca Jackson-Spence Barts Experimental Cancer Medicine Centre joins Pedro C Barata, MD MSc FACP Case Comp Cancer Ctr to discuss final overall survival data and circulating tumor DNA analysis for patients with advanced papillary renal cancer in the CALYPSO

Our International Clinical Trials Day event is happening now! Organised by our @bartsecmc patient group. You are welcome to pop in to West Wing and listen to our speakers. Up first is Tom Powles talking all about personalised cancer vaccines 💉🔬

Attendees at our Barts Experimental Cancer Medicine Centre Patient event are currently listening to Prof Marco Gerlinger St Bartholomew's Hospital GI Cancer Centre talking all about gastrointestinal cancers and ctDNA. Happening now in West Wing St Bart’s hospital Barts Health ECMC Network (@ecmc-uk.bsky.social)

Next up is Dr Usman Bashir Barts Health talking all about Artificial Intelligence (AI) in cancer early diagnosis. A fascinating talk #InternationalClinicalTrialsDay #ICTD25 ECMC Network (@ecmc-uk.bsky.social)

Thank you to everyone who came and took part in our International Clinical Trials Day event! If you are interested in keeping up to date with our events, please send us message or email [email protected] ✨ ECMC Network (@ecmc-uk.bsky.social) Barts Health